Wellness Briefing: How stem cell therapy innovator Acorn Biolabs is (legally) scaling in the US, plus news
Culture Index
Score Breakdown
Relevance
9/25
Freshness
25/25
Authority
18/20
Brand Signal
6/15
Depth
4/15
5-Axis Cultural Radar
For the Wellness Briefing, Glossy sat down with Drew Taylor, Ph.D, CEO and co-founder of Acorn Biolabs, a Canadian regenerative medicine company that turns one’s own hair follicles into stem cells for longevity- and aesthetic-focused therapies. The company is tapping U.S. doctors to scale its You secretome offering in the U.S. Additionally, functional fragrance has a new wellness player, the chief
